December 9, 2015
FDA nods for Vonvendi for von Willebrand disease
The U.S. Food and Drug Administration on Tuesday approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of…
Pharmaceuticals, Biotechnology and Life Sciences
The U.S. Food and Drug Administration on Tuesday approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of…